Male circumcision for prevention of heterosexual acquisition of HIV in men.

PubWeight™: 2.32‹?› | Rank: Top 2%

🔗 View Article (PMID 12917962)

Published in Cochrane Database Syst Rev on January 01, 2003

Authors

N Siegfried1, M Muller, J Volmink, J Deeks, M Egger, N Low, H Weiss, S Walker, P Williamson

Author Affiliations

1: South African Cochrane Centre, Medical Research Council, PO Box 19070, Tygerberg, South Africa.

Associated clinical trials:

Randomized Control Trial of Shang Ring Versus Forceps-guided Adult Male Circumcision in Southwestern Uganda. | NCT01757938

Articles citing this

Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis (2009) 6.96

Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review. AIDS Behav (2006) 5.86

Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex Transm Infect (2006) 5.11

HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet (2006) 2.86

Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis (2007) 2.83

Sexual abstinence only programmes to prevent HIV infection in high income countries: systematic review. BMJ (2007) 2.36

Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries. BMC Infect Dis (2006) 2.10

Male circumcision and HIV/AIDS: challenges and opportunities. Lancet (2007) 1.63

Sexual Risk Behaviours and Willingness to Be Circumcised among Uncircumcised Adult Men in Uganda. PLoS One (2015) 1.43

Acceptability of male circumcision among mothers with male children in Mysore, India. AIDS (2008) 1.39

Male circumcision and HIV prevention: ethical, medical and public health tradeoffs in low-income countries. J Med Ethics (2007) 1.34

Economic evaluations of adult male circumcision for prevention of heterosexual acquisition of HIV in men in sub-Saharan Africa: a systematic review. PLoS One (2010) 1.28

The first randomised trial of male circumcision for preventing HIV: what were the ethical issues? PLoS Med (2005) 1.26

Safety and efficacy of nontherapeutic male circumcision: a systematic review. Ann Fam Med (2010) 1.25

Behavioral aspects of male circumcision for the prevention of HIV infection. Curr HIV/AIDS Rep (2009) 1.22

HIV-prevention science at a crossroads: advances in reducing sexual risk. Curr Opin HIV AIDS (2009) 1.18

Translation of biomedical prevention strategies for HIV: prospects and pitfalls. J Acquir Immune Defic Syndr (2013) 1.12

Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections. Annu Rev Med (2013) 1.08

Circumcision for prevention against HIV: marked seasonal variation in demand and potential public sector readiness in Soweto, South Africa. Implement Sci (2007) 1.05

Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand. BMC Public Health (2010) 0.99

What counts as reliable evidence for public health policy: the case of circumcision for preventing HIV infection. BMC Med Res Methodol (2011) 0.90

New ways of preventing HIV infection: thinking simply, simply thinking. Philos Trans R Soc Lond B Biol Sci (2006) 0.89

Understanding partial protection and HIV risk and behavior following voluntary medical male circumcision rollout in Kenya. Health Educ Res (2013) 0.88

Community and healthcare providers' perspectives on male circumcision: a multi-centric qualitative study in India. PLoS One (2014) 0.88

Male circumcision and HIV infection risk. World J Urol (2011) 0.88

Circumcision Status and Risk of HIV Acquisition during Heterosexual Intercourse for Both Males and Females: A Meta-Analysis. PLoS One (2015) 0.84

Efforts to Control Sexually Transmitted Infections As a Means to Limit HIV Transmission: What Is the Evidence? Curr Infect Dis Rep (2005) 0.82

Impact of Male Circumcision among heterosexual HIV cases: comparisons between three low HIV prevalence countries. Isr J Health Policy Res (2015) 0.81

Routine circumcision: the opposing view. Can Urol Assoc J (2007) 0.79

The future of HIV prevention: control of sexually transmitted infections and circumcision interventions. Infect Dis Clin North Am (2007) 0.79

Should female health providers be involved in medical male circumcision? Narratives of newly circumcised men in Malawi. Malawi Med J (2013) 0.79

Amplified transmission of HIV-1: missing link in the HIV pandemic. Trans Am Clin Climatol Assoc (2006) 0.77

Epidemiology of HIV/AIDS in adults in Malawi. Malawi Med J (2006) 0.75

A comparison of sexual risk behaviours and HIV seroprevalence among circumcised and uncircumcised men before and after implementation of the safe male circumcision programme in Uganda. BMC Public Health (2016) 0.75

Exposé of misleading claims that male circumcision will increase HIV infections in Africa. J Public Health Africa (2011) 0.75

Can routine neonatal circumcision help prevent human immunodeficiency virus transmission in the United States? Am J Mens Health (2009) 0.75

Circumcision - A new approach for a different cosmetic result. Hippokratia (2014) 0.75

Articles by these authors

The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med (2001) 37.70

Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ (2001) 20.65

The hazards of scoring the quality of clinical trials for meta-analysis. JAMA (1999) 17.00

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature (1999) 12.95

Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol (2001) 12.72

Misleading meta-analysis. BMJ (1995) 11.94

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol (2000) 9.70

Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med (2001) 9.68

Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol (1998) 9.13

Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol (2000) 7.95

Effects of treatment for intestinal helminth infection on growth and cognitive performance in children: systematic review of randomised trials. BMJ (2000) 7.30

Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ (2001) 7.13

Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses (2001) 6.00

A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol (1965) 5.71

Who benefits from medical interventions? BMJ (1994) 5.58

A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess (2007) 5.29

Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study. BMJ (2001) 4.89

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet (1999) 4.83

Early enteral feeding versus "nil by mouth" after gastrointestinal surgery: systematic review and meta-analysis of controlled trials. BMJ (2001) 4.47

Socioeconomic differentials in wealth and health. BMJ (1993) 4.32

Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med (1996) 4.28

Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology (2003) 4.08

Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet (1983) 4.02

Magnesium and myocardial infarction. Lancet (1994) 3.74

Cooperativity of the glucocorticoid receptor and the CACCC-box binding factor. Nature (1988) 3.69

The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol (1996) 3.68

Grey literature in meta-analyses of randomized trials of health care interventions. Cochrane Database Syst Rev (2007) 3.51

Cloned pigs produced by nuclear transfer from adult somatic cells. Nature (2000) 3.51

HIV and male circumcision--a systematic review with assessment of the quality of studies. Lancet Infect Dis (2005) 3.49

Many transcription factors interact synergistically with steroid receptors. Science (1988) 3.49

Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med (1995) 3.48

Suicide in psychiatric hospital in-patients. Risk factors and their predictive power. Br J Psychiatry (2000) 3.38

Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ (1998) 3.37

Virulence factors of Porphyromonas gingivalis. Periodontol 2000 (1999) 3.36

Binding of -bungarotoxin to acetylcholine receptors in mammalian muscle (snake venom-denervated muscle-neonatal muscle-rat diaphragm-SDS-polyacrylamide gel electrophoresis). Proc Natl Acad Sci U S A (1972) 3.34

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA (1999) 3.34

Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. Health Technol Assess (2001) 3.32

Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial. BMJ (2000) 3.29

The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. J Virol (1992) 3.28

Smoking and health promotion in Nazi Germany. J Epidemiol Community Health (1994) 3.20

HIV and AIDS, other sexually transmitted diseases, and tuberculosis in ethnic minorities in United Kingdom: is surveillance serving its purpose? BMJ (1997) 3.13

Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ (1998) 3.12

Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene (2010) 3.04

Postal urine specimens: are they a feasible method for genital chlamydial infection screening? Br J Gen Pract (1999) 3.02

Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev (2004) 2.95

Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ (2000) 2.92

Beta-blockers for hypertension. Cochrane Database Syst Rev (2007) 2.91

A subfamily of P-type ATPases with aminophospholipid transporting activity. Science (1996) 2.90

Do all men attending departments of genitourinary medicine need to be screened for non-gonococcal urethritis? Int J STD AIDS (2002) 2.81

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. Circulation (1999) 2.78

Fab-7 functions as a chromatin domain boundary to ensure proper segment specification by the Drosophila bithorax complex. Genes Dev (1996) 2.78

Is antenatal syphilis screening still cost effective in sub-Saharan Africa. Sex Transm Infect (2003) 2.77

The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res (1996) 2.76

Funding clinical research. Lancet (1999) 2.63

Teaching critical appraisal skills in health care settings. Cochrane Database Syst Rev (2001) 2.57

Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology (1995) 2.48

Death of Diana, Princess of Wales. Her death and funeral rate as traumatic stressors. BMJ (1997) 2.47

64-Slice computed tomography angiography in the diagnosis and assessment of coronary artery disease: systematic review and meta-analysis. Heart (2008) 2.42

Functional organization of human supplementary motor cortex studied by electrical stimulation. J Neurosci (1991) 2.41

Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev (2006) 2.40

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat Med (1996) 2.39

The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess (2005) 2.38

The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics. Soz Praventivmed (1994) 2.38

Genital Chlamydia trachomatis infections in Uppsala County, Sweden, 1985-1993: declining rates for how much longer? Sex Transm Dis (1995) 2.36

Commentary: understanding it all--health, meta-theories, and mortality trends. BMJ (1997) 2.35

The genesis and collapse of third millennium north mesopotamian civilization. Science (1993) 2.33

Does uptake of antenatal HIV testing depend on the individual midwife? Cross sectional study. BMJ (1998) 2.27

Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection. Ann Intern Med (1997) 2.27

The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess (2007) 2.27

Are randomised controlled trials in the BMJ different? BMJ (2001) 2.26

A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health Technol Assess (2005) 2.24

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis (2001) 2.24

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess (2007) 2.23

Better substrates for bacterial transglycosylases. J Am Chem Soc (2001) 2.22

Transport into mitochondria and intramitochondrial sorting of the Fe/S protein of ubiquinol-cytochrome c reductase. Cell (1986) 2.21

A Polycomb and GAGA dependent silencer adjoins the Fab-7 boundary in the Drosophila bithorax complex. Genetics (1997) 2.18

Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. N Engl J Med (1999) 2.17

Improving searching skills and evidence retrieval. J R Coll Physicians Lond (1999) 2.17

Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. Int J Tuberc Lung Dis (2011) 2.15

Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol (2000) 2.14

Hip fractures and fluoridation in Utah's elderly population. JAMA (1992) 2.13

Meeting the challenge of interpreting high-resolution single nucleotide polymorphism array data in prenatal diagnosis: does increased diagnostic power outweigh the dilemma of rare variants? BJOG (2013) 2.12

Acute pain management: scientific evidence revisited. Br J Anaesth (2006) 2.09

A randomised controlled trial to compare minimally invasive glucose monitoring devices with conventional monitoring in the management of insulin-treated diabetes mellitus (MITRE). Health Technol Assess (2009) 2.09

Activity of two different silencer elements of the chicken lysozyme gene can be compensated by enhancer elements. EMBO J (1987) 2.07

National Confidential Enquiry into counselling for genetic disorders by non-geneticists: general recommendations and specific standards for improving care. Br J Obstet Gynaecol (1999) 2.06

When can odds ratios mislead? Odds ratios should be used only in case-control studies and logistic regression analyses. BMJ (1998) 2.05

Immobilized proteins in buffer imaged at molecular resolution by atomic force microscopy. Biophys J (1990) 2.04

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet (2002) 2.01

Regadenoson-induced bradycardia and hypotension: possible mechanism and antidote. J Nucl Cardiol (2014) 1.99

Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J (2002) 1.97

The 1.9 A crystal structure of Escherichia coli MurG, a membrane-associated glycosyltransferase involved in peptidoglycan biosynthesis. Protein Sci (2000) 1.90

Role of Mycoplasma genitalium and Ureaplasma urealyticum in acute and chronic nongonococcal urethritis. Clin Infect Dis (2001) 1.89

Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance). Radiology (1994) 1.87